AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Thursday November 23 2023 its half year interim results for the period ended September 30 2023. The release will be issued at around 09:00.
This will be followed by a presentation by management at 10:00 by teleconference. The presentation material which will be referred to by management will be issued at around 09:00 and will also be available on the company’s website aftpharm.com.
To attend the conference call, you will need to use the pre-registration link below. Once you have completed this you will be provided with dial in details and a unique pin code.
Registration Link: AFT conference call November 23 2023
For and on behalf of AFT Pharmaceuticals Limited, Malcolm Tubby, CFO.
For more information:
Dr Hartley Atkinson
Managing Director
AFT Pharmaceuticals
Tel:+64 9488 0232
Richard Inder
The Project
Tel: +64 21 645 643
